Exelixis Inc. Common Stock vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Exelixis Inc. Common Stock trades at $59.77 (market cap $14.62B), while Vivmark Residential Common Shares of Beneficial Interest trades at $61.11 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is far larger — about 3.2× Exelixis Inc. Common Stock's market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.68% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Vivmark Residential Common Shares of Beneficial Interest for 1 Days on average.
| EXEL | VMRK | |
|---|---|---|
Market Cap | $14.62B | $46.41B |
Volume | 2,684,957 | 6,584,008 |
Sector | Health | Real Estate |
52-Week High | $59.13 | $70.15 |
52-Week Low | $34.54 | $57.98 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $13.95B | $55.52B |
Dividend Yield | — | 4.68% |
Trailing returns across standard periods
Latest headlines on both assets
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →